ConAlliance Advises the Sole Shareholder of Dr. Dr. Wagner Health & Care Group on Sale to ORPEA

ConAlliance serves as the exclusive M&A advisor to Dr. Dr. Stephan Wagner, the sole shareholder, in the sale of 100% of the shares of Dr. Dr. Wagner Health & Care Group to the ORPEA Group.

About Dr. Dr. Wagner Health & Care

Dr. Dr. Wagner Health & Care is one of Austria's largest and most significant private providers in the fields of spa medicine, rehabilitation, care, and everyday assistance. Founded in 1987 by Dr. Dr. Stephan Wagner and headquartered in Salzburg, the group operates 18 healthcare facilities across Austria, including seven spa clinics, five rehabilitation clinics (special hospitals), six nursing homes—two of which have day centers—and one facility for the daily care of individuals with special needs and intellectual disabilities.

Approximately 80% of the clinic and care property is owned by the group.

In 2016, Dr. Dr. Wagner Group generated revenues exceeding €60 million. With around 1,800 beds and approximately 1,300 employees, Dr. Dr. Wagner Health & Care is one of the largest employers in the Austrian healthcare market. The completion of this transaction is subject to antitrust review and approval by the Austrian Federal Competition Authority, as well as standard closing conditions. The parties have agreed to keep the transaction details confidential.

Today, the group operates under the name OPTIMAMED. For more information, visit https://www.optimamed.at/.

About ORPEA and SeneCura

ORPEA is one of the leading operators of senior care facilities in Europe. In Austria, ORPEA has been represented by the SeneCura Group since 2015, operating 59 healthcare and nursing facilities in Austria (www.senecura.at). The ORPEA Group has a network of 775 healthcare facilities with nearly 80,000 beds, approximately 40% of which are in France and about 60% outside France (in Germany, Austria, Belgium, China, Spain, Italy, Czech Republic, Poland, and Switzerland). ORPEA is listed on Euronext Paris (ISIN: FR0000184798) (www.orpea-corp.com).

Leadership of the Transaction at ConAlliance

The ConAlliance team for this transaction was led by Günter Carl Hober, Managing Partner (overall lead), and ConAlliance partner Martin E. Franz.

Back to top